Title: Metachronous Breast Cancer- A Case Report
Authors: Major. Mirza Baig, Arpit Diwadi, Pooja Verma, Arundithi, Anuradha
DOI: https://dx.doi.org/10.18535/jmscr/v10i8.05
Abstract
We are presenting a rare case of bilateral breast cancer case of 60 year old female. By definition Synchronous cancers were defined as those occurring within 6 months of the first primary cancer, while Metachronous cancers were defined as those occurring more than 6 months later. Bilateral synchronous breast cancer is an uncommon finding in women presenting with multiple breast lumps. Metachronous breast tumors account for 5% to 6% of cancer cases whereas Synchronous breast tumor reported to account nearly 1% to 2% of women with breast cancer..
Keywords: Metachronous lesion, Synchronous lesion, Infiltrating ductal carcinoma.
References
- Donovan AJ. Bilateral breast cancer . Surg Clin North Am. 1990;70:1141–1149. [PubMed] [Google Scholar]
- Chaudery MA, Mills RR, Hoskins EOL. Bilateral breast cancer: a prospective study of disease incidence. Br J Surg. 1984;71:711–714. [PubMed] [Google Scholar]
- Gollamudi DV, Gelman RS, Peiro G. Breast conserving therapy for stage Ⅰ–Ⅱ synchronous bilateral breast carcinoma . Cancer. 1997;79:1362–1369. [PubMed] [Google Scholar]
- Warren S, Gates O. Multiple primary malignant tumours. A survey of the literature and statistical study . AM J Cancer. 1932;16:1358–1405. [Google Scholar]
- Carmichael AR, Bendall S. The long–term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours . Eur J Surg Oncology. 2002;28:388–391. [PubMed] [Google Scholar]
- Hartman M, Czene K. Incidence and Prognosis of Synchronous and Metachronous Bilateral Breast Cancer . Journal of Clinical Oncology. 2007;25: 4210–4216. [PubMed] [Google Scholar]
- McPherson K, Steel CM. ABC of breast diseases: Breast cancer epidemiology, risk factors, and genetics. BMJ. 2000;321:624–628. [PMC free article] [PubMed] [Google Scholar]
- Bailey MJ, Royce C. Bilateral carcinoma of the breast . Br J Surg. 1980;67:414–416. [Google Scholar]
- Fisher B, Dignam J. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor–positive tumors. J Natl Cancer Inst. 1996;88:1529–1542. [PubMed] [Google Scholar]